Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom

The use of egg yolk antibodies—IgY technology—represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants to achieve the hyperimmunization of laying hens plays a key role in the succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiva, Carlos Leónidas, Cangelosi, Adriana, Mariconda, Virginia, Celi Castillo, Ana Beatriz, Joaquim, Patricia Estefania, Geoghegan, Patricia, Fernandez Miyakawa, Mariano Enrique, Chacana, Pablo
Formato: info:ar-repo/semantics/artículo
Lenguaje:Inglés
Publicado: Springer 2023
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12123/13956
https://link.springer.com/article/10.1007/s00253-023-12409-3
https://doi.org/10.1007/s00253-023-12409-3
_version_ 1855037040381394944
author Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Celi Castillo, Ana Beatriz
Joaquim, Patricia Estefania
Geoghegan, Patricia
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo
author_browse Cangelosi, Adriana
Celi Castillo, Ana Beatriz
Chacana, Pablo
Fernandez Miyakawa, Mariano Enrique
Geoghegan, Patricia
Joaquim, Patricia Estefania
Leiva, Carlos Leónidas
Mariconda, Virginia
author_facet Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Celi Castillo, Ana Beatriz
Joaquim, Patricia Estefania
Geoghegan, Patricia
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo
author_sort Leiva, Carlos Leónidas
collection INTA Digital
description The use of egg yolk antibodies—IgY technology—represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants to achieve the hyperimmunization of laying hens plays a key role in the success of the production of high levels of the antibodies. In the present work, two different adjuvant systems (Freund’s adjuvants and MontanideTM ISA 71 VG) were compared to produce IgY anti-Bothrops alternatus. For the first immunization, formalin-inactivated Salmonella was added to MontanideTM ISA 71 VG to emulate Freund’s complete adjuvant which includes a mycobacteria antigen. After eight immunizations, IgY produced by using either adjuvant was able to neutralize the lethal activity of the venom in a mouse model, but differences were found regarding the recognition of components of the venom between the two adjuvants tested. Overall, MontanideTM adjuvant used in this work could be a good alternative choice to produce antibodies capable of neutralizing the lethality of complex antigens. This adjuvant is commercially available and used in the formulation of several poultry vaccines and could be used for the IgY technology instead of traditional immunomodulators such as Freund’s adjuvants.
format info:ar-repo/semantics/artículo
id INTA13956
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher Springer
publisherStr Springer
record_format dspace
spelling INTA139562023-02-13T14:12:43Z Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom Leiva, Carlos Leónidas Cangelosi, Adriana Mariconda, Virginia Celi Castillo, Ana Beatriz Joaquim, Patricia Estefania Geoghegan, Patricia Fernandez Miyakawa, Mariano Enrique Chacana, Pablo Egg Yolk Adjuvants Mass Spectrometry Antibodies Neutralization Yema de Huevo Coadyuvantes Espectrometría de Masas Anticuerpos Neutralización IgY Antibodies Anticuerpos IgY The use of egg yolk antibodies—IgY technology—represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants to achieve the hyperimmunization of laying hens plays a key role in the success of the production of high levels of the antibodies. In the present work, two different adjuvant systems (Freund’s adjuvants and MontanideTM ISA 71 VG) were compared to produce IgY anti-Bothrops alternatus. For the first immunization, formalin-inactivated Salmonella was added to MontanideTM ISA 71 VG to emulate Freund’s complete adjuvant which includes a mycobacteria antigen. After eight immunizations, IgY produced by using either adjuvant was able to neutralize the lethal activity of the venom in a mouse model, but differences were found regarding the recognition of components of the venom between the two adjuvants tested. Overall, MontanideTM adjuvant used in this work could be a good alternative choice to produce antibodies capable of neutralizing the lethality of complex antigens. This adjuvant is commercially available and used in the formulation of several poultry vaccines and could be used for the IgY technology instead of traditional immunomodulators such as Freund’s adjuvants. Instituto de Patobiología Fil: Leiva, Carlos Leónidas. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología Veterinaria; Argentina Fil: Leiva, Carlos Leónidas. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Cangelosi, Adriana. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Mariconda, Virginia. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Celi Castillo, Ana Beatriz. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología Veterinaria; Argentina Fil: Celi Castillo, Ana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Joaquim, Patricia Estefania. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología Veterinaria; Argentina Fil: Joaquim, Patricia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Geoghegan, Patricia. Ministerio de Salud. Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán”. Centro Nacional de Control de Calidad de Biológicos; Argentina Fil: Fernandez Miyakawa, Mariano Enrique. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología Veterinaria; Argentina Fil: Fernandez Miyakawa, Mariano Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Chacana, Pablo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Patobiología Veterinaria; Argentina Fil: Chacana, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina 2023-02-13T14:05:17Z 2023-02-13T14:05:17Z 2023-02 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/13956 https://link.springer.com/article/10.1007/s00253-023-12409-3 1432-0614 0175-7598 https://doi.org/10.1007/s00253-023-12409-3 eng info:eu-repo/semantics/restrictedAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf Springer Applied Microbiology and Biotechnology (Published: 01 February 2023)
spellingShingle Egg Yolk
Adjuvants
Mass Spectrometry
Antibodies
Neutralization
Yema de Huevo
Coadyuvantes
Espectrometría de Masas
Anticuerpos
Neutralización
IgY Antibodies
Anticuerpos IgY
Leiva, Carlos Leónidas
Cangelosi, Adriana
Mariconda, Virginia
Celi Castillo, Ana Beatriz
Joaquim, Patricia Estefania
Geoghegan, Patricia
Fernandez Miyakawa, Mariano Enrique
Chacana, Pablo
Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title_full Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title_fullStr Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title_full_unstemmed Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title_short Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
title_sort use of adjuvant isa vg 71 to produce neutralizing egg yolk antibodies against bothropic venom
topic Egg Yolk
Adjuvants
Mass Spectrometry
Antibodies
Neutralization
Yema de Huevo
Coadyuvantes
Espectrometría de Masas
Anticuerpos
Neutralización
IgY Antibodies
Anticuerpos IgY
url http://hdl.handle.net/20.500.12123/13956
https://link.springer.com/article/10.1007/s00253-023-12409-3
https://doi.org/10.1007/s00253-023-12409-3
work_keys_str_mv AT leivacarlosleonidas useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT cangelosiadriana useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT maricondavirginia useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT celicastilloanabeatriz useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT joaquimpatriciaestefania useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT geogheganpatricia useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT fernandezmiyakawamarianoenrique useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom
AT chacanapablo useofadjuvantisavg71toproduceneutralizingeggyolkantibodiesagainstbothropicvenom